N07BC01 - Buprenorphine |
Not porphyrinogenic |
NP |
Rationale
Opioid, substrate of CYP3A4. Four references consider it safe.
Chemical description
Partial opioid agonist/antagonist used in treatment of opioid dependence, metabolized by CYP3A4 and glucuronidation. Inhibitor of CYP3A4 and 2D6.
Personal communication
Clinical experience (Sweden) of non-porphyrinogenicity.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | Australian List
Australian Porphyria Association No longer maintained
|
|
| 2. | French List
Centre Français des Porphyries
|
|
| 3. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 4. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames